MPM BioVentures 2018 LLC, 10% Owner at iTeos Therapeutics, Inc. (ITOS), sold 170,222 shares at $36.21 ($5.7M) on 2021-11-23, disclosed to the SEC on 2021-11-24.
Scheduled sale ($5.7M) by 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 15,671 | $0 | 0.0% |
| 2 | $37.16 | 9,307 | $346K | 6.1% |
| 3 | $37.16 | 9,307 | $346K | 6.1% |
| 4 | $37.81 | 11,807 | $446K | 7.9% |
| 5 | $37.81 | 11,807 | $446K | 7.9% |
| 6 | $36.21 | 19,645 |
| $711K |
| 12.6% |
| 7 | $36.21 | 19,645 | $711K | 12.6% |
| 8 | $36.50 | 359 | $13K | 0.2% |
| 9 | $35.20 | 4,868 | $171K | 3.0% |
| 10 | $35.20 | 4,868 | $171K | 3.0% |
| 11 | $36.05 | 18,343 | $661K | 11.7% |
| 12 | $36.05 | 18,343 | $661K | 11.7% |
| 13 | $37.02 | 13,126 | $486K | 8.6% |
| 14 | $37.02 | 13,126 | $486K | 8.6% |
| Total | $33.24 avg | 170,222 | $5.7M | 100% |
| Filing → |